C Flashcards
What is the indication of HAS-BLED tool?
Assess bleeding risk
Please note: NICE guidance recommends using the ORBIT bleeding risk assessment tool when considering starting anticoagulation in people with atrial fibrillation, and that a direct oral anticoagulant should be used first line in people considered to be at risk of stroke.
when does NICE guidance recommened the ORBIT tool instead of HAS- BLED tool?
when considering starting anticoagulation in people with atrial fibrillation,
and that a direct oral anticoagulant should be used first line in people considered to be at risk of stroke.
State the ORBIT tool, (Scores range from 0 to 7 based on the scores):
There is a score of 2 points for:
* Males with haemoglobin less than 130g/L or hematocrit less than 40%
- Females with haemoglobin less than 120g/L or hematocrit less than 36%
- People with history of bleeding for example Gl bleeding, intracranial bleeding or haemorrhagic stroke
There is a score of 1 point for:
* People aged over 74 years
- People with egfr of less than 60 ml/min
- People treated with antiplatelets
What do the ORBIT tool scores stipulate:
0-2 score = low risk
3 = medium risk
4-7 = high risk
What is the indication of CHA2-DS2-VASc tool?
Assess a person’ stroke risk
C = congestive heart failure/left ventricular dysfunction (1 score)
H = hypertension (1 score)
A2 = age 75 or aged 75+ (2 scores)
D = diabetes mellitus (1 score)
S2 = stroke/TIA (2 scores)
V = vascular disease, prior myocardial infarction, peripheral arterial disease or aortic
plaque (1 score)
A = age 65-74 (1 score)
Sc = sex category female (1 score)
What patients do not require antithrombotic for stroke prevention:
CHA2- DS2- VASc scores
Low risk:
Males = score 0
Females = score 1
What is recommended in treatment of acute ischaemic stroke:
Alteplase - if it can be administered within 4.5 hours of symptom onset and if intracranial hemorrhage has been excluded
Which direct-acting oral anticoagulant DOAC is given to people with AF and a CHADVASC score of 2+:
Apixaban, edoxaban, dabigatran, rivaraoxaban
If DOACS are not suitable then offer a vitamin k antagonist
what should we offer patients if DOACs are not suitable?
a vitamin K antagonsit
in what conditions do we need target INR of 2.5:
Treatment of DVT or pulmonary embolism
Atrial fibrillation
Cardioversion
Dilated cardiomyopathy
Myocardial infarction
in what conditions do we need a target INR of 3.5
Recurrent DVT
Mechanical prosthetic heart valves
State the advice of what to do when there is a haemorrhage in terms of: major bleeding
Major bleeding =
stop warfarin, give phytomenadione (vit k) by slow IV injection
Give dried prothrombin complex
Fresh frozen plasma can be given but is less effective
State the advice of what to do when there is a haemorrhage in terms of: INR > 8.0 minor bleeding
stop warfarin
give phytomenadione (vit k) by slow IV injection
repeat dose of phytomenadione if INR still too high
after 24 hours restart warfarin when INR < 5.0
State the advice of what to do when there is a haemorrhage in terms of: INR > 8.0, no bleeding:
Stop warfarin
give phytomenadione (vit k) by mouth using the intravenous preparation orall (unlicensed use)
repeat dose of phytomenadione if INR still too high
after 24 hours restart warfarin when INR < 5.0
State the advice of what to do when there is a haemorrhage in terms of: INR 5.0-8.0, minor bleeding
stop warfarin
give phytomenadione (vit k) by slow IV injection
restart warfarin when INR < 5.0
State the advice of what to do when there is a haemorrhage in terms of: NT 5.0-8.0, no bleeding:
Withhold 1 or 2 doses of warfarin and reduce subsequent maintenance dose
Unexplained bleeding at therapeutic levels - always investigate possibility of underlying cause e.g., unsuspected renal or gastro-intestinal tract pathology
State the treatment of rate-control treatment:
Standard beta-blocker (other than sotalol) or a rate-limiting CB (diltiazem or verapamil) as first line treatment for most people with AF
Base the choice of drug on the person’s symptoms, heart rate, comorbidities and preferences
Note: do not offer amiodarone for long term rate-control
What could be prescribed for people with non-paroxysmal AF:
Digoxin
What is antidote for dabigatran
Idarucizumab
What is the antidote for rivaroxaban and apixaban
Andexanet alfa
Define Torsade de pointes:
Form of ventricular tachycardias associated with long QT syndrome
(hypokalaemia, severe bradycardia, genetic predisposition is also implicated)
Which beta-blocker drug should not be used in torsade de pointes:
Sotalol
What is the treatment for torsade de pointes:
IV magnesium sulphate
What conditions is IV adenosine contraindicated in:
COPD/Asthma
What is the duration of action of IV adenosine:
8-10 seconds
What is given if adenosine is contraindicated:
Verapamil
State ONE serious interaction with verapamil:
beta-blockers
State the classes of anti-arrhythmic drugs:
Class 1: membrane stabilising (lidocaine, fleicanide)
Class 2: beta-blockers (including sotalol)
Class 3: amiodarone
Class 4: CCBs (includes verapamil)
State some side effects of amiodarone:
Constipation, corneal deposits, hypothyroidism, photosensitivity, hypotension, taste altered,
Corneal microdeposits - if vision impaired or optic neuropathy occurs, amiodarone must be stopped to prevent blindness
Thyroid function - can cause hypo/hyperthyroidism
Hepatotoxicity - if severe liver dysfunction or if signs of liver disease occurs
Pulmonary toxicity - new or progressive shortness of breath or cough develops
What is the initial loading dose for amiodarone
200 mg 3 times a day for 1 week
then reduced to 200 mg twice daily for a further week
followed by maintenance dose, usually 200 mg daily or the minimum dose required to control arrhythmia.
What are the monitoring requirements for amiodarone:
Thyroid before and every 6 months
Lits before and every 6 months
Serum potassium before treatment
Chest x-ray before treatment
What are common significant interactions of amiodarone?
Amiodarone + grapefruit juice = increase plasma amiodarone concentrations
Amiodarone + (warfarin (phenytoin) (digoxin)
Amiodarone + statins = increased risk of myopathy
Amiodarone + (quinolones) (macrolides) (TCAs) (SSRIs) (Lithium) (chloroquine,
mefloquine) (sulpride, pimozide, amisulpride) = QT prolongation, increased risk of
ventricular arrythmia
If patient is taking amiodarone with concomitant sofofbuvir, daclatasvir, simeprevir, ledipasvir:
Recognise signs of bradycardia and heart block
SOB {shortness of breath)
light headedness
palpitations
Fainting,
unusual tiredness
chest pain
= seek urgent help
What is digoxin:
Narrow therapeutic cardiac glycoside drug that increases the force of myocardial contraction and reduces conductivity within the AV node
What are the therapeutic levels of digoxin
0.7-2.0 nanograms/mL
Blood samples taken 6 hours after the previous dose, but ideally 8-12 hours afterwards
What are the adverse effects of digoxin?
Cardiac adverse effects - sinoatrial and atrioventricular block
Premature ventricular contractions
PR prolongation and ST-segment depression
What are the non-cardiac adverse effects of digoxin?
Nausea, vomiting, and less commonly diarrhea. Nausea, in particular is indicative of overdose
Visual abnormalities i.e., blurred or yellow vision
CNS effects such as weakness, dizziness, co fusion, apathy, malaise, headache, depression and psychosis
Thrombocytopenia and agranulocytosis are rare
Gynaecomastia in men following prolonged administration
State the monitoring requirements for digoxin:
For plasma-digoxin concentration assay, blood should be taken at least 6 hours after a dose
Monitor serum electrolytes and renal function (toxicity increased by electrolyte disturbances)
What key drug interactions should you be aware of for digoxin:
Avoid TCAS
venlafaxine
beta-blockers
bupropion
diuretics
St john’s wart
PPi’s
CCB’s (diltiazem, verapamil, nifedipine)
What are the signs of digoxin toxicity?
Bradycardia
nausea
vomiting
diarrhea
abdominal pain
rash
blurred or yellow vision
Hypokalaemia
hypercalcaemia
hypoxia
hypomagnesemia
What is the maximum daily grams a female can take tranexamic acid:
4g
What can be given prior to general or orthopedic surgery for prophylaxis:
Low molecular weight heparin
What is preferred in patients with renal impairment:
Heparin (unfractionated)
Which anticoagulant is preferred for patient undergoing bariatric, abdominal, thoracic, cardiac, fragility, hip surgery:
Fondaparinux sodium
After surgery, parmacological prophylaxis should be carried on for:
7 days post-surgery
28 days post major cancer surgery in abdomen
30 days post spinal surgery
What is the thromboembolism prophylaxis in pregnancy:
Low molecular weight heparin (tinzaparin, enoxaparin, dalteparin)
Treatment stopped during onset of labour